MICROBIX BIOSYSTEMS INC (MBX.CA) Stock Price, Quote, News and Overview
TSX:MBX - Toronto Stock Exchange - CA59501P1045 - Common Stock - Currency: CAD
MBX.CA Quote, Performance and Key Statistics
TSX:MBX (5/7/2025, 7:00:00 PM)
0.38
-0.01 (-2.56%)
The current stock price of MBX.CA is 0.38 CAD. In the past month the price increased by 2.7%. In the past year, price increased by 15.15%.
MBX.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 236.65M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 235.89M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 190.72M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 175.18M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 74.31M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 14.71 | 68.55M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 65.22M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 57.06M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 56.01M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 53.76M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 50.90M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 30.85M |
Related stock screener links
About MBX.CA
Company Profile
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The company enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.
Company Info
MICROBIX BIOSYSTEMS INC
265 Watline Avenue
Mississauga ONTARIO L4Z 1P3 CA
CEO: Cameron Groome
Employees: 70
Phone: 19053618910
MICROBIX BIOSYSTEMS INC / MBX.CA FAQ
What is the stock price of MICROBIX BIOSYSTEMS INC today?
The current stock price of MBX.CA is 0.38 CAD. The price decreased by -2.56% in the last trading session.
What is the ticker symbol for MICROBIX BIOSYSTEMS INC stock?
The exchange symbol of MICROBIX BIOSYSTEMS INC is MBX and it is listed on the Toronto Stock Exchange exchange.
On which exchange is MBX.CA stock listed?
MBX.CA stock is listed on the Toronto Stock Exchange exchange.
What is the price forecast or stock price prediction for MICROBIX BIOSYSTEMS INC stock?
5 analysts have analysed MBX.CA and the average price target is 0.92 CAD. This implies a price increase of 141.58% is expected in the next year compared to the current price of 0.38. Check the MICROBIX BIOSYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MICROBIX BIOSYSTEMS INC worth?
MICROBIX BIOSYSTEMS INC (MBX.CA) has a market capitalization of 53.59M CAD. This makes MBX.CA a Micro Cap stock.
How many employees does MICROBIX BIOSYSTEMS INC have?
MICROBIX BIOSYSTEMS INC (MBX.CA) currently has 70 employees.
What are the support and resistance levels for MICROBIX BIOSYSTEMS INC (MBX.CA) stock?
MICROBIX BIOSYSTEMS INC (MBX.CA) has a support level at 0.36 and a resistance level at 0.4. Check the full technical report for a detailed analysis of MBX.CA support and resistance levels.
Is MICROBIX BIOSYSTEMS INC (MBX.CA) expected to grow?
The Revenue of MICROBIX BIOSYSTEMS INC (MBX.CA) is expected to grow by 7.14% in the next year. Check the estimates tab for more information on the MBX.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MICROBIX BIOSYSTEMS INC (MBX.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MBX.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MBX.CA, evaluating the profitability, health, valuation and growth aspects
- MICROBIX BIOSYSTEMS INC (MBX.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MICROBIX BIOSYSTEMS INC (MBX.CA) Sales and EPS estimates to see what analysts future expectations are.
- MICROBIX BIOSYSTEMS INC (MBX.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MICROBIX BIOSYSTEMS INC (MBX.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- MICROBIX BIOSYSTEMS INC (MBX.CA) Stock Chart to make your own analysis
- MICROBIX BIOSYSTEMS INC (MBX.CA) Latest news and press-releases to stay up to date.
Does MICROBIX BIOSYSTEMS INC (MBX.CA) stock pay dividends?
MBX.CA does not pay a dividend.
When does MICROBIX BIOSYSTEMS INC (MBX.CA) report earnings?
MICROBIX BIOSYSTEMS INC (MBX.CA) will report earnings on 2025-05-14.
What is the Price/Earnings (PE) ratio of MICROBIX BIOSYSTEMS INC (MBX.CA)?
The PE ratio for MICROBIX BIOSYSTEMS INC (MBX.CA) is 38. This is based on the reported non-GAAP earnings per share of 0.01 and the current share price of 0.38 CAD. Check the full fundamental report for a full analysis of the valuation metrics for MBX.CA.
MBX.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MBX.CA. When comparing the yearly performance of all stocks, MBX.CA is a bad performer in the overall market: 65.9% of all stocks are doing better.
MBX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MBX.CA. MBX.CA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
MBX.CA Financial Highlights
Over the last trailing twelve months MBX.CA reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS decreased by -21.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.34% | ||
| ROA | 4.89% | ||
| ROE | 6.65% | ||
| Debt/Equity | 0.22 |
MBX.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to MBX.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 50% and a revenue growth 7.14% for MBX.CA